- Home
- JHI vs SGMO Comparison
JHI vs SGMO Comparison
Compare JHI & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JHI
- SGMO
- Stock Information
- Founded
- JHI 1971
- SGMO 1995
- Country
- JHI United States
- SGMO United States
- Employees
- JHI N/A
- SGMO N/A
- Industry
- JHI Trusts Except Educational Religious and Charitable
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- JHI Finance
- SGMO Health Care
- Exchange
- JHI Nasdaq
- SGMO Nasdaq
- Market Cap
- JHI 120.3M
- SGMO 122.8M
- IPO Year
- JHI N/A
- SGMO 2000
- Fundamental
- Price
- JHI $13.86
- SGMO $0.49
- Analyst Decision
- JHI
- SGMO Buy
- Analyst Count
- JHI 0
- SGMO 6
- Target Price
- JHI N/A
- SGMO $4.50
- AVG Volume (30 Days)
- JHI 29.5K
- SGMO 5.3M
- Earning Date
- JHI 01-01-0001
- SGMO 08-05-2025
- Dividend Yield
- JHI 6.80%
- SGMO N/A
- EPS Growth
- JHI N/A
- SGMO N/A
- EPS
- JHI 1.05
- SGMO N/A
- Revenue
- JHI N/A
- SGMO $63,756,000.00
- Revenue This Year
- JHI N/A
- SGMO N/A
- Revenue Next Year
- JHI N/A
- SGMO N/A
- P/E Ratio
- JHI $12.47
- SGMO N/A
- Revenue Growth
- JHI N/A
- SGMO 239.92
- 52 Week Low
- JHI $11.63
- SGMO $0.37
- 52 Week High
- JHI $13.40
- SGMO $3.18
- Technical
- Relative Strength Index (RSI)
- JHI 63.47
- SGMO 47.00
- Support Level
- JHI $13.77
- SGMO $0.50
- Resistance Level
- JHI $14.00
- SGMO $0.54
- Average True Range (ATR)
- JHI 0.11
- SGMO 0.05
- MACD
- JHI 0.01
- SGMO 0.00
- Stochastic Oscillator
- JHI 74.55
- SGMO 49.35
About JHI John Hancock Investors Trust
John Hancock Investors Trust is a United States-based diversified, closed-end management investment company. It seeks to generate income for distribution to its shareholders. The secondary objective of the company is capital appreciation. The portfolio composition of the fund comprises corporate bonds, U.S. government agencies, preferred securities, asset-backed securities, common stocks, short-term investments, and others.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.